Page last updated: 2024-11-05

ethoheptazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethoheptazine: major descriptor (65-83); on-line search AZEPINES (65-83); Index Medicus search ETHOHEPTAZINE (65-83); RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6469
CHEMBL ID170797
CHEBI ID135074
SCHEMBL ID24581
MeSH IDM0262514

Synonyms (44)

Synonym
ethoheptazine
1h-azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester
77-15-6
ethyl 1-methyl-4-phenylazepane-4-carboxylate
hsdb 3326
1-methyl-4-carbethoxy-4-phenylhexamethyleneimine
4-carbethoxy-1-methyl-4-phenylhexamethylenimine
zactane
etoheptazina [inn-spanish]
wy 401
1-methyl-4-carbethoxy-4-phenylhexamethylenimine
azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester
hexahydro-1-methyl-4-phenyl-4-azepinecarboxylic acid ethyl ester
ethoheptazinum [inn-latin]
aethoheptazin
brn 0088192
ethyl hexahydro-1-methyl-4-phenyl-azepine-4-carboxylate
ethyl heptazine
4-carbethoxy-1-methyl-4-phenylazacycloheptane
einecs 201-007-3
CHEBI:135074
CHEMBL170797
AKOS016010413
3a4g3a848u ,
unii-3a4g3a848u
ethoheptazine [inn:ban]
ethoheptazinum
etoheptazina
4-22-00-01044 (beilstein handbook reference)
ethoheptazine [inn]
ethoheptazine [who-dd]
ethoheptazine [hsdb]
ethoheptazine [vandf]
ethoheptazine [mi]
SCHEMBL24581
ethyl 1-methyl-4-phenyl-4-azepanecarboxylate #
ethyl hexahydro-1-methyl-4-phenyl-1h-azepine-4-carboxylate
WGJHHMKQBWSQIY-UHFFFAOYSA-N
DTXSID7023017
DB08988
4-ethoxycarbonyl-1-methyl-4-phenyl-hexahydro-1h-azepine
Q5404408
aethoheptazin;ethyl heptazine;wy 401
EN300-18562833
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
azepanes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID640615Clearance in human liver microsomes at 1 uM measured after 60 mins by HPLC analysis2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (92.86)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.29 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies1 (7.14%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]